CCP
GILD icon

Carmel Capital Partners’s Gilead Sciences GILD Stock Holding History

Carmel Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-187
Closed -$14K – 357
2023
Q3 		$14K Buy
+187
New +$14.4K 0.01% 400
2023
Q2 		– Sell
-1,892
Closed -$157K – 447
2023
Q1 		$157K Sell
1,892
-1,245
-40% -$103K 0.09% 140
2022
Q4 		$269K Buy
+3,137
New +$248K 0.19% 106
2022
Q1 		– Sell
-3,212
Closed -$233K – 128
2021
Q4 		$233K Buy
+3,212
New +$221K 0.17% 101

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmel Capital Partners's GILD Position: Q4 2023 in Review

Carmel Capital Partners sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 187 shares — an estimated $14K sold.

Carmel Capital Partners first reported a position in GILD in Q4 2021 and held it in 4 quarters. The position peaked at $269K in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Carmel Capital Partners reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 187 Gilead Sciences shares in Q4 2023, an estimated $14K.
  • Carmel Capital Partners first reported a position in Gilead Sciences in Q4 2021 and held it in 4 quarters.
  • Carmel Capital Partners's Gilead Sciences position peaked at $269K in Q4 2022.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.